🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchSurvodutide (GCG/GLP-1) — anyone have experience? Page 3

Survodutide (GCG/GLP-1) — anyone have experience?

stefan_berlin Sat, Mar 28, 2026 at 5:44 AM 16 replies 838 viewsPage 3 of 4
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Mar 31, 2026 at 2:31 PM#11
hans_munich said:
Start from the measurement rather than the conclusion.

Thank you for spelling out the reasoning rather than just the conclusion. Sending this to two other people who asked me the same thing last week.

49 24TirzTom, TrialTracker_MD, JennaRN and 46 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Apr 1, 2026 at 11:07 AM#12

Clinical perspective, offered as context rather than as advice. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

48 23traveltech_sara, AttorneyGrant, DebRD_ATL and 45 others
Reply Quote Save Share Report
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
Apr 2, 2026 at 7:42 AM#13
Dr.PathRoch said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

Correct me if the detail matters more than I have assumed.

47 22FitDadDave, RunnerRach, TrialNerd_Beth and 44 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Apr 3, 2026 at 4:17 AM#14

Adding the numbers, since they settle part of this. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

Last edited: Apr 3, 2026 at 7:17 AM
46 21kate.chem, DataDave, Dr.GutHealth and 43 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Apr 4, 2026 at 12:51 AM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out.

45 20PurityPaulOR, MaxMetOK, MounjBrad and 42 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register